you give up on it. Everybody knows biotech's with data as good as bavi's don't stay down in the 2-3$ range for long. Institutions don't take risks buying before data because they don't have to. They know daytraders will sell cheap and they work it. Upgrade after they close their short positions and go long. Happens every time...
if Cramer brought it up himself - contrarian indicator par exellence ... routinely helps his industry buddies get out of positions. You are something like 80% secure in going against him in whatever he says
You people are idiots. Today was shear profit taking and nervous nelly trading. How many days in a row do you expect sp to rise??? CHTP will be fine regardless of storms and greedy little China men. But you people probably won't be
you would have made beaucoup bucks going against AF with CHTP and their drug approval high drama to which he contributed as expected. AF is a drama queen and his political science rather than finance background makes perfect sense given the bs. But the market has gotten wise to his shillery. Timing is everything in politics and AF is merely a contrarian indicator if anything.
AF? not so much lately... he lauded CHTP's prospects pre-approval couple weeks ago. Post-approval sp going no where...
JJ ensures Cowen BOD has made "significant progress" regarding ((((transaction)))) to address debt... And the debt is really what's holding sp down...hmmmm. When he's saying this at Cowen he you better bet he means it.
heard some rumblings...20's. Northera is very profitable in Japan already. orphan drug status was somewhat of a hoax but it comes down to this: US clinicians want Norhtera period and CHTP jumped through all FDA hoops. Now it's payday. the big boys want this badly and all kinds of games are going on
Gotta love these shorts for being so informative. Sharing is caring. Meanwhile sp was higher 3 years ago... ain't nothin in the current sp but scared shorty bs. approval more likely and blast off more likely. Ima buy me some more Tuesday if price is good.